{"DataElement":{"publicId":"4940372","version":"2","preferredName":"Platinum Compound Therapeutic Procedure Resistance Sensitivity Status","preferredDefinition":"A response to address the platinum-based treatment resistant/sensitivity status from initial treatment to a specified time.","longName":"PLAT_STAT","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"4939593","version":"1","preferredName":"Platinum Compound Therapeutic Procedure Resistance Process Hypersensitivity","preferredDefinition":"A chemotherapy compound that contains a platinum atom. Platinum compounds do not contain alkyl groups but do cause DNA crosslinks and adducts similar to alkylating agents. DNA crosslinks and adducts ultimately lead to the induction of apoptosis._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._A Resistance Process consists of activities of biologic molecules or complexes involved in processes that maintain immunity to, or counteract, defeat, or withstand the effects of, an antagonistic agent._An immune response that occurs following exposure to an innocuous antigen, but that does not require the presence of preformed antibodies to the antigen.","longName":"4939591v1.0:4940351v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"4939591","version":"1","preferredName":"Platinum Compound","preferredDefinition":"Inorganic compounds which contain platinum as the central atom.","longName":"C1450","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Platinum Compound","conceptCode":"C1450","definition":"A chemotherapy compound that contains a platinum atom. Platinum compounds do not contain alkyl groups but do cause DNA crosslinks and adducts similar to alkylating agents. DNA crosslinks and adducts ultimately lead to the induction of apoptosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CB8DF32-14AA-BEEC-E050-BB89AD4333EB","latestVersionIndicator":"Yes","beginDate":"2015-08-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-08-07","modifiedBy":"ONEDATA","dateModified":"2015-08-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4940351","version":"1","preferredName":"Therapeutic Procedure Resistance Process Hypersensitivity","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.:A Resistance Process consists of activities of biologic molecules or complexes involved in processes that maintain immunity to, or counteract, defeat, or withstand the effects of, an antagonistic agent.:An immune response that occurs following exposure to an innocuous antigen, but that does not require the presence of preformed antibodies to the antigen.","longName":"C49236:C41546:C3114","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Resistance Process","conceptCode":"C41546","definition":"A Resistance Process consists of activities of biologic molecules or complexes involved in processes that maintain immunity to, or counteract, defeat, or withstand the effects of, an antagonistic agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hypersensitivity","conceptCode":"C3114","definition":"An immune response that occurs following exposure to an innocuous antigen, but that does not require the presence of preformed antibodies to the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CBAF43C-41E3-84DE-E050-BB89AD4334BD","latestVersionIndicator":"Yes","beginDate":"2015-08-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-08-07","modifiedBy":"ONEDATA","dateModified":"2015-08-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CB8DF32-14B8-BEEC-E050-BB89AD4333EB","latestVersionIndicator":"Yes","beginDate":"2015-08-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-08-07","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"8/10/15/ released/tt_8/7/15 curated for Theradex/tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4939612","version":"2","preferredName":"Platinum Compound Therapeutic Procedure Status","preferredDefinition":"Inorganic compounds which contain platinum as the central atom._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._A condition or state at a particular time.","longName":"PLAT_TX_STAT","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"43","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Greater than 3 months and less than or equal to 6 months","valueDescription":"Greater than three months and less than or equal to six months","ValueMeaning":{"publicId":"5633700","version":"1","preferredName":"Greater than three months and less than or equal to six months","longName":"5633700","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.: One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.: A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.: One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Three","conceptCode":"C66834","definition":"A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Month","conceptCode":"C29846","definition":"One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Less Than or Equal To","conceptCode":"C61586","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Six","conceptCode":"C66837","definition":"A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Month","conceptCode":"C29846","definition":"One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"46F0D8F0-9200-7615-E053-F662850A5344","latestVersionIndicator":"Yes","beginDate":"2017-01-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2017-01-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"46F0D8F0-9219-7615-E053-F662850A5344","beginDate":"2017-01-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2017-01-25","modifiedBy":"ONEDATA","dateModified":"2017-01-25","deletedIndicator":"No"},{"value":"Less than or equal to 3 months","valueDescription":"Less than or equal to three months","ValueMeaning":{"publicId":"5633701","version":"1","preferredName":"Less than or equal to three months","longName":"5633701","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.: A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.: One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Less Than or Equal To","conceptCode":"C61586","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Three","conceptCode":"C66834","definition":"A natural number greater than 2 and less than 4 and the quantity that it denotes: the sum of two and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Month","conceptCode":"C29846","definition":"One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"46F0D8F0-9227-7615-E053-F662850A5344","latestVersionIndicator":"Yes","beginDate":"2017-01-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2017-01-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"46F0D8F0-9240-7615-E053-F662850A5344","beginDate":"2017-01-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2017-01-25","modifiedBy":"ONEDATA","dateModified":"2017-01-25","deletedIndicator":"No"},{"value":"6 to 12 months (Platinum Sensitive)","valueDescription":"6 to 12 months (Platinum Sensitive)","ValueMeaning":{"publicId":"4940334","version":"1","preferredName":"6 to 12 months (Platinum Sensitive)","longName":"4940334","preferredDefinition":"A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.: Used as a function word to indicate direction, purpose, or movement.: A natural number greater than 11 and less than 13 and the quantity that it denotes.: One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.: A metal that is an important component of some anticancer drugs, such as cisplatin and carboplatin.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.: An immune response that occurs following exposure to an innocuous antigen, but that does not require the presence of preformed antibodies to the antigen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Six","conceptCode":"C66837","definition":"A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Twelve","conceptCode":"C113426","definition":"A natural number greater than 11 and less than 13 and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Month","conceptCode":"C29846","definition":"One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Platinum","conceptCode":"C756","definition":"An element with atomic symbol Pt, atomic number 78, and atomic weight 195.09.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hypersensitivity","conceptCode":"C3114","definition":"An immune response that occurs following exposure to an innocuous antigen, but that does not require the presence of preformed antibodies to the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CBAF43C-415B-84DE-E050-BB89AD4334BD","latestVersionIndicator":"Yes","beginDate":"2015-08-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-08-07","modifiedBy":"TAYLORT","dateModified":"2015-08-10","changeDescription":"8/7/15 Theradex preferred long name/tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"46F0BFD4-EB67-4D8D-E053-F662850ADA46","beginDate":"2015-08-07","endDate":null,"createdBy":"MAESKEB","dateCreated":"2017-01-25","modifiedBy":"ONEDATA","dateModified":"2017-01-25","deletedIndicator":"No"},{"value":"Greater than 12 months (Platinum Sensitive)","valueDescription":"Greater than 12 months (Platinum Sensitive) ","ValueMeaning":{"publicId":"4940335","version":"1","preferredName":"Greater than 12 months (Platinum Sensitive) ","longName":"4940335","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A natural number greater than 11 and less than 13 and the quantity that it denotes.: One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.: A metal that is an important component of some anticancer drugs, such as cisplatin and carboplatin.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.: An immune response that occurs following exposure to an innocuous antigen, but that does not require the presence of preformed antibodies to the antigen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Twelve","conceptCode":"C113426","definition":"A natural number greater than 11 and less than 13 and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Month","conceptCode":"C29846","definition":"One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Platinum","conceptCode":"C756","definition":"An element with atomic symbol Pt, atomic number 78, and atomic weight 195.09.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hypersensitivity","conceptCode":"C3114","definition":"An immune response that occurs following exposure to an innocuous antigen, but that does not require the presence of preformed antibodies to the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CBAF43C-4186-84DE-E050-BB89AD4334BD","latestVersionIndicator":"Yes","beginDate":"2015-08-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-08-07","modifiedBy":"TAYLORT","dateModified":"2015-08-10","changeDescription":"8/7/15 Theradex preferred long name/tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"46F0BFD4-EB71-4D8D-E053-F662850ADA46","beginDate":"2015-08-07","endDate":null,"createdBy":"MAESKEB","dateCreated":"2017-01-25","modifiedBy":"ONEDATA","dateModified":"2017-01-25","deletedIndicator":"No"},{"value":"0 to 6 months (Platinum Resistant)","valueDescription":"0 to 6 months (Platinum Resistant)","ValueMeaning":{"publicId":"4940333","version":"1","preferredName":"0 to 6 months (Platinum Resistant)","longName":"4940333","preferredDefinition":"A mathematical element that when added to another number yields the same number; the cardinal number meaning one less than one.: Used as a function word to indicate direction, purpose, or movement.: A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.: One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.: A metal that is an important component of some anticancer drugs, such as cisplatin and carboplatin.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.: A Resistance Process consists of activities of biologic molecules or complexes involved in processes that maintain immunity to, or counteract, defeat, or withstand the effects of, an antagonistic agent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Zero","conceptCode":"C70430","definition":"A mathematical element that when added to another number yields the same number; the cardinal number meaning one less than one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Six","conceptCode":"C66837","definition":"A natural number greater than 5 and less than 7 and the quantity that it denotes: the sum of five and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Month","conceptCode":"C29846","definition":"One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Platinum","conceptCode":"C756","definition":"An element with atomic symbol Pt, atomic number 78, and atomic weight 195.09.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Resistance Process","conceptCode":"C41546","definition":"A Resistance Process consists of activities of biologic molecules or complexes involved in processes that maintain immunity to, or counteract, defeat, or withstand the effects of, an antagonistic agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CBAF43C-412F-84DE-E050-BB89AD4334BD","latestVersionIndicator":"Yes","beginDate":"2015-08-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-08-07","modifiedBy":"TAYLORT","dateModified":"2015-08-10","changeDescription":"8/7/15-Theradex preferred long name/tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"46F0BFD4-EB7B-4D8D-E053-F662850ADA46","beginDate":"2015-08-07","endDate":null,"createdBy":"MAESKEB","dateCreated":"2017-01-25","modifiedBy":"ONEDATA","dateModified":"2017-01-25","deletedIndicator":"No"},{"value":"Following Prior Platinum Therapy","valueDescription":"Following Prior Platinum Therapy","ValueMeaning":{"publicId":"6034355","version":"1","preferredName":"Following Prior Platinum Therapy","longName":"6034355","preferredDefinition":"Subsequent; immediately following in time or order.: Earlier in time or order.: A metal that is an important component of some anticancer drugs, such as cisplatin and carboplatin.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Next","conceptCode":"C53286","definition":"Subsequent; immediately following in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Platinum","conceptCode":"C756","definition":"An element with atomic symbol Pt, atomic number 78, and atomic weight 195.09.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F272EFC-AF59-2A7A-E053-F662850AD03A","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5F272EFC-AF72-2A7A-E053-F662850AD03A","beginDate":"2017-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-29","modifiedBy":"ONEDATA","dateModified":"2017-11-29","deletedIndicator":"No"},{"value":"Cisplatin Ineligible and first line","valueDescription":"Cisplatin Ineligible and first line","ValueMeaning":{"publicId":"6034356","version":"1","preferredName":"Cisplatin Ineligible and first line","longName":"6034356","preferredDefinition":"An alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition.: The state or quality of being disqualified by law, rule, or provision.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The preferred standard treatment for a particular condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cisplatin","conceptCode":"C376","definition":"An alkylating-like inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Ineligibility","conceptCode":"C40412","definition":"The state or quality of being disqualified by law, rule, or provision.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"First-Line Therapy","conceptCode":"C45792","definition":"The preferred standard treatment for a particular condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5F272EFC-AF81-2A7A-E053-F662850AD03A","latestVersionIndicator":"Yes","beginDate":"2017-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5F272EFC-AF9A-2A7A-E053-F662850AD03A","beginDate":"2017-11-29","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-11-29","modifiedBy":"ONEDATA","dateModified":"2017-11-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4939611","version":"1","preferredName":"Platinum Compound Therapeutic Procedure Status","preferredDefinition":"Inorganic compounds which contain platinum as the central atom.:An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.:A condition or state at a particular time.","longName":"C1450:C49236:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Platinum Compound","conceptCode":"C1450","definition":"A chemotherapy compound that contains a platinum atom. Platinum compounds do not contain alkyl groups but do cause DNA crosslinks and adducts similar to alkylating agents. DNA crosslinks and adducts ultimately lead to the induction of apoptosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1CB98FF2-84CD-C3DB-E050-BB89AD4377AA","latestVersionIndicator":"Yes","beginDate":"2015-08-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2015-08-07","modifiedBy":"ONEDATA","dateModified":"2015-08-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"46F0BFD4-EB4F-4D8D-E053-F662850ADA46","latestVersionIndicator":"Yes","beginDate":"2015-08-07","endDate":null,"createdBy":"MAESKEB","dateCreated":"2017-01-25","modifiedBy":"TAYLORT","dateModified":"2017-11-29","changeDescription":"11/29/17 tt added 2 PVs. 1/25/17 Versioned to remove min length_8/10/15 approved and released/tt_8/7/15 curated for Theradex/tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Theradex - 2","type":"Alternate Question Text","description":"Platinum Free Interval","url":null,"context":"Theradex"},{"name":"Platinum Status","type":"Preferred Question Text","description":"Platinum Status","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"46F0EFFF-97F2-4AA8-E053-F662850A4C89","latestVersionIndicator":"Yes","beginDate":"2015-08-07","endDate":null,"createdBy":"MAESKEB","dateCreated":"2017-01-25","modifiedBy":"MAESKEB","dateModified":"2017-01-25","changeDescription":"1/25/17 Versioned VD and CDE_8/10/15 approved and released/tt_8/7/15 curated by tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}